News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Jane Brandman, BPharm, MS

Articles by Jane Brandman, BPharm, MS

Cost-effectiveness of Extended Adjuvant Letrozole Therapy After 5 Years of Adjuvant Tamoxifen Therapy in Postmenopausal Women With Early-stage Breast Cancer

ByThomas E. Delea, MSIA,Jonathan Karnon, MSc, PhD,Robert E. Smith, MD,Stephen R. D. Johnston, MD, PhD, FRCP,Jane Brandman, BPharm, MS,Jennifer C. Y. Sung, PharmD,Paul E. Goss, MD, PhD, FRCPC, FRCP(UK)

July 15th 2006

Latest Updated Articles

Cost-effectiveness of Extended Adjuvant Letrozole Therapy After 5 Years of Adjuvant Tamoxifen Therapy in Postmenopausal Women With Early-stage Breast Cancer
Published: July 15th 2006 | Updated:

Trending on AJMC

House Votes to Extend ACA Subsidies, Eyes Turn to Senate

5 Key Health Care Changes During Trump’s First Year Back in Office

J&J Agreement Brings 15 of 17 Pharma Companies Into Trump's Drug-Pricing Effort

Maternal Morbidity Increased in States Enacting TRAP Laws

Detectable ctDNA Potential Predictor of Gastroesophageal, Esophageal Cancer Recurrence

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.